Lupin Limited has informed the Exchange regarding a press release dated April 17, 2025, titled "Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur".
Press Release Apr 17 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Lupin Announces the Acquisition of Renascience in the United Kingdom
- Press Release Mar 22 2025
- Press Release Mar 21 2025
- Press Release Mar 20 2025
- Press Release Mar 17 2025
Later from Lupin
- Press Release Apr 23 2025
- Press Release Apr 24 2025
- Press Release May 07 2025
- Press Release May 08 2025
- Press Release May 13 2025
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin